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President’s message
“The true sign of maturity and excellence in a university is its ability to
contribute to the knowledge of mankind, in its own society and beyond.”

Firoz Rasul
President and Chief
Executive Officer

Those words were spoken by AKU’s founder and Chancellor, His
Highness the Aga Khan, at our 2003 convocation. Seventeen years
later – and in the midst of the COVID-19 pandemic – how does the
University measure against the standard he articulated? Certainly AKU
is generating far more knowledge today than ever before. Between
2015 and 2019, the number of research papers published by our faculty
in peer-reviewed journals increased by more than 50 per cent. And
our research productivity continued to increase through the first three
quarters of 2020. We can also take pride in the fact that much of our
work has been funded by or carried out in collaboration with globally
renowned institutions such as the Bill & Melinda Gates Foundation,
the World Health Organization, the University of Washington and the
University of California, San Francisco.
Yet output data alone cannot capture the impact of our research
and innovation on people’s lives. As the following pages make clear,
numerous people across Asia and Africa are benefitting from our
investigations. As of this writing, COVID-19 has infected nearly 60 million
people and killed almost 1.4 million globally. AKU is working to deliver
crucial insights into the novel coronavirus, and is participating in an
array of international clinical trials to identify vaccines, treatments and
tests that can help to halt the pandemic. Our researchers are also at the
forefront of efforts to address an unprecedented outbreak of HIV/AIDS
among children in Pakistan, to understand the biology of malnutrition, to
identify emerging viruses and to help East Africa’s news media thrive in
the digital age. In addition, they are producing cutting-edge scholarship
in the humanities and social sciences that can help us to understand
how centuries of cross-cultural interaction have shaped present-day
identities.
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Message from the academy
It is our pleasure to report that AKU’s research continues to attract
increasing support from a wide range of partners and funders located
both within the countries we serve and in Europe and North America.
The number of extramural grants the University received in 2019
represents an all-time high, and a nearly 50 per cent increase from just
a few years ago. Meanwhile, the value of grants received in 2019 is
2.5 times higher than the figure five years ago. In total, the University
attracted more than US$ 150 million in research funding in 2015-2019.
As 2020 began, we were looking forward to seeing these figures grow
– and with them, AKU’s contributions to addressing major challenges
in a wide range of fields and in varying geographies. And despite the
turmoil created by the COVID-19 pandemic, we are on track to attract
more research funding in 2020 than in the previous year. Our largest
grant, amounting to more than US$ 6 million, came from Gavi, the
Vaccine Alliance, and is supporting research to assess the impact of the
introduction of typhoid conjugate vaccine in Pakistan. In a year defined
by the pandemic, almost one-third of all grants the University submitted
were related to research on the novel coronavirus. This reflects AKU’s
health-related research prowess, but it also demonstrates our ability to
rapidly pivot to address important new problems. Meanwhile, 2020 has
been an especially productive year for our scholars outside the health
sciences: though the year is not yet over at the time of this writing, AKU
faculty have already published more peer-reviewed papers in the social
sciences in 2020 than in all of 2019.
We are deeply grateful to all those who have supported AKU’s research
efforts over the past year, including our institutional funders, individual
donors, alumni, former staff and volunteers. And we wish to thank all our
faculty and staff, who worked so hard and overcame so many obstacles
to ensure that the University could continue to deliver innovative new
research and scholarship amid challenging circumstances.

In short, in keeping with our Chancellor’s vision, AKU is making
important contributions to humanity’s storehouse of knowledge –
contributions that are saving and changing lives, especially in lowincome and marginalised communities.

Dr Carl Amrhein, Provost and Vice President, Academic

But with the world facing its gravest public health crisis in recent
memory, much remains to be done, and we cannot stand still. We must
recognise that knowledge is constantly evolving, and that expanding the
frontiers of understanding requires a spirit of restless inquiry. Therefore
we will continue to strive to fulfill AKU’s potential as a research university,
and to demonstrate the maturity and excellence our Chancellor intended.

Professor Fauziah Rabbani, Associate Vice Provost, Research

Professor Anjum Halai, Vice Provost and Dean, Faculty of Arts and
Sciences

Dr Alex Awiti, Vice Provost, East Africa
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Rising to an
unprecedented
challenge

The world has not seen an upheaval
like the COVID-19 pandemic since
the great influenza pandemic of 19181919. In the 11 months since the first
few cases were detected in a localised
outbreak in Wuhan, China, the novel
coronavirus has spread to every country
on earth and affected countless people.
Pakistan and Afghanistan were
exposed to COVID-19 very early
through pilgrims returning from Iran.
Shortly thereafter, East Africa received
travelers from Europe with the virus.
Notwithstanding preventive measures
and stringent official strategies,
community transmission ensued.
In all geographies, the Aga Khan
University’s hospitals, health centres
and laboratories had to rapidly
transform to deal with a highly infectious
illness and its consequences. This
had to be done with staff and patient
safety in mind, often amidst huge
personal risks and difficulties in safe
travel and transportation. Patient
care had to shift to standards of care
and personal protection hitherto
unseen, and consultations had to
move to virtual platforms, requiring
4

a major shift to deliver secure and
effective communications. Meanwhile,
faculty launched a massive effort to
begin teaching students online.
The whole University family stood
as one, with thousands of faculty
and staff members making the
personal sacrifices needed to mount
an exemplary response. AKU’s
performance in such circumstances
is a testament to the resilience of our
greatest asset: our human resources.
In ordinary circumstances, research
and scholarship would take a back
seat to the daily challenge of clinical
services and survival. Not so at AKU.
The University developed one of the
first online courses designed to rapidly

The AKU family stood
as one, with faculty
and staff making
personal sacrifices to
mount an exemplary
response.

increase capacity for the provision
of quality clinical care in intensive
care settings. It also developed a
widely recognised mobile-phone
app to rapidly screen and triage
suspected cases of COVID-19.
Faculty and students quickly
pivoted, launching research efforts
to address a range of challenges of
immediate concern, such as basic
epidemiology, risk-factor identification
for prognosis and sophisticated
sero-epidemiology studies to assess
population immunity. Many of these
competitive research projects were
nationally or internationally funded,
and many were collaborations with
other researchers and institutions.
AKU also rapidly responded to
government requests for advice in
each of its key geographies, and
participated in major global trials
of therapeutic agents, including
the Unity and Solidarity trials.
Faculty members undertook in-depth
evaluations of the direct and indirect
effects of COVID-19 on the health
and nutrition of women and children

in South Asia, and also undertook
an in-depth assessment of the
epidemiological burden of disease
in the Muslim world. Other projects
are ongoing to assess mitigation
strategies and efforts to rebuild
resilience within health systems.
AKU faculty, staff and students
have withstood the first wave of an
unprecedented global challenge
with aplomb, applying evidenceinformed policies and pragmatically
adapting to local realities.
The financial challenges that are
inevitable in any organisation were
met with a unique, equity-focused
sharing of the burden. As we
recover from this unique crisis, the
research enterprise will move back
to prioritising issues that have taken
a back seat during the crisis. But we
will not forget the lessons we have
learned, and AKU will continue to
address the challenges created by
a once-in-a-century pandemic.
Professor Zulfiqar Bhutta
Founding Director, AKU Institute for
Global Health and Development
5
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AKU’s typhoid
vaccine study is first
of its kind globally
Amid an outbreak of drug-resistant
typhoid, researchers evaluate the
effectiveness of a new vaccine

AKU played a crucial role in addressing
an outbreak of extensively drug-resistant
typhoid in Sindh, and contributed to
Pakistan’s decision to become the
first country in the world to use a new
typhoid vaccine on a routine basis.
Now the University is conducting the
world’s first evaluation of the impact
of the typhoid conjugate vaccine in a
routine immunisation programme.
Caused by the bacterium Salmonella
typhi and characterised by symptoms
including fever and diarrhoea, typhoid
afflicts 14 million people and kills roughly
220,000 every year, typically in poor
communities in Asia and Africa that
lack access to safe drinking water.
As the bacterium evolves to become
extensively drug-resistant, it becomes
an even greater threat because the
risk of complications increases and
treatment grows more difficult and
expensive. Improved water and
sanitation facilities play a key role in
preventing new cases of typhoid, but
they represent an expensive, long-term

fix. In the short-term, the only solution
is a vaccine, which prevents people
from catching typhoid in the first place.
“The vaccine represents the most
cost-effective and rapid approach to
preventing new cases of typhoid,”
said Associate Professor Farah Naz
Qamar, principal investigator of the
study, which is being funded by Gavi,
an alliance of international organisations
that works to increase vaccination
rates, especially in poor countries.
To determine whether the vaccine has
had an impact on antibiotic resistance
and has helped decrease the number
of typhoid cases, the study will analyse
data on cases from hospitals across
Sindh and Punjab over the three years

Increasing resistance
to a range of antibiotics
is making it more
difficult and expensive
to treat typhoid.

prior to the vaccine’s introduction,
comparing it to data on cases that have
emerged up to three years after the
launch of the immunisation campaign.
Researchers are also following a
group of children who have received
the vaccine to assess the duration
of their immune response following
administration of a single dose of
the typhoid conjugate vaccine.
The study is expected to inform
decisions on whether booster shots
are needed to provide better and
longer-lasting protection against
the disease. The evaluation of the
impact of the vaccine will provide
crucial information for policymakers
in other typhoid-endemic countries
like Bangladesh and Nepal, which are
considering introducing the vaccine.
Dr Qamar’s co-investigators at
AKU are Assistant Professor Sonia
Qureshi, Assistant Professor
Momin Kazi, Associate Professor
Seema Irfan, Senior Instructor Tahir
Yousafzai and Professor Asad Ali.
7

High-stakes exams,
like the one shown in
this pre-pandemic
photo, did not take
place in Pakistan in
2020 due to COVID-19.

AKU research informs
national examination
policy during
COVID-19 disruption
Policymakers turned to AKU’s Examination
Board when high-stakes exams were cancelled

Around the world, the COVID-19
pandemic has caused the cancellation
of standardised examinations
used for university admissions and
promotion to higher grades, leading
countries to adopt different methods
for dealing with the consequences.
In Pakistan, the Aga Khan University
Examination Board (AKU-EB) played
a key role in formulating an evidencebased national policy used to address
the fact that Secondary School
Certificate (SSC) exams and Higher
Secondary School Certificate (HSCC)
exams were cancelled in order to limit
the spread of the virus. SSC exams
are taken in 9th and 10th grades
and students’ scores are considered
in admissions decisions by higher
secondary schools. HSSC exams are
taken in 11th and 12th grades and
students’ scores are considered in
university admissions decisions.
The Board’s involvement was the result
of a request for assistance from Federal

8

Education Minister Shafqat Mahmood
to AKU-EB Director Dr Shehzad Jeeva,
who is also the chairman of the Inter
Board Committee of Chairmen (IBCC),
Federal Ministry of Education and
Professional Training. Pakistan has 33
examination boards, each of which
has the power to set examination
policy. The IBCC exists to enable
coordination among exam boards.
“The continuity of education of more
than 4 million students across Pakistan
was at stake,” Dr Jeeva said. “We were
asked to create an evidence-based
approach that could be uniformly
applied by the country’s examination
boards to prevent further disruption
to students’ education. The goal was
a solution based on the principles
of fairness, equality and merit.”
AKU-EB’s assessment and operations
teams studied data on the exam
performance of 1 million students in
grades 9-12 over four years. Their
predictive psychometric statistical

analysis showed that for SSC
qualifications (grades 9 and 10), the
performance of grade 9 students in
2019 could be used to predict how they
would have performed on the grade 10
exams cancelled in 2020. Similarly, for
HSSC qualifications (grades 11 and 12),
the performance of grade 11 students in
2019 could be used to predict how they
would have performed on the grade 12
exams cancelled in 2020. In addition,
there was strong statistical evidence
that grade 10 and 12 students typically
improve their performance by 3 per
cent compared to their grade 9 and 11
scores. Therefore, it was recommended
that an additional 3 per cent be added
to scores of grade 10 and 12 students.
AKU-EB’s recommendation was
unanimously approved by all relevant
government agencies, including the
Higher Education Commission; the
coordinating body of all the country’s
education ministers, the Inter Provincial
Education Ministers Conference; and
the federal body that brings together all

government departments to coordinate
COVID-19 response, the National
Command and Operation Centre.
The policy was rolled out across
the nation in September 2020 and
used to award exam scores and
promote students across Pakistan.
AKU-EB's technical expertise and
leadership role in building support
for a coordinated, transparent and
fair solution that allowed the nation’s
students to continue their education
were acknowledged by Federal
Education Minister Mahmood.
“The Federal Minister of Education was
delighted with the outcome and to see
a national-level policy recommendation
receive such unanimous support,”
Dr Jeeva said. “Other nations have
struggled with controversies over results
and promotion. The absence of these
issues, including no reports of litigation
in Pakistan, speaks to the strength of
the evidence we were able to marshal.”
9
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Studies will help
East African news
media navigate the
digital age
AKU will highlight examples
of successful innovation by the
region’s media outlets

A pair of studies by AKU’s Graduate
School of Media and Communications
(GSMC) in Nairobi aims to help East
Africa’s news media navigate the
changes brought by the internet,
mobile phones and social media.
While the rise of digital media has
wreaked havoc on older news
organisations in many countries, the
situation in East Africa has been less
dire. For example, prior to the COVID-19
pandemic, Kenyan newspaper revenues
had been growing modestly, and Kenya
was one of just four countries in the
world where newspaper revenues were
expected to continue increasing over
the next five years, according to a report
by PricewaterhouseCoopers. Moreover,
trust in news organisations in Kenya
remains high by global standards.
Nevertheless, change is happening, and
rapidly. Since 2014, radio’s audience
share in Kenya has plunged, although it
remains the number one news source,
according to a report by Reelforge and

TIFA Research. Meanwhile, with internet
subscriptions having nearly tripled in
five years, the percentage of people
who get their news online via their
mobile phones has greatly increased.
GSMC’s State of the Media Report aims
to be the most detailed publication
of its kind, providing information
on news organisations’ audiences,
finances and influence; professional
and industry organisations; the legal
and regulatory framework in which
the media operates; the education
and training of media professionals;
and notable developments.

The tripling of internet
subscriptions has
greatly increased the
percentage of people
who get news via their
mobile phones.

It will initially cover Kenya, but
will eventually expand to cover
neighbouring countries.
The School’s Innovation for Media
Viability Study will deliver insights
that East African media organisations
can use as they seek to achieve
commercial success and deliver highquality content in the digital age.
Researchers will conduct an online
survey of journalists and executives at
nearly 450 news organisations, as well
as follow-up interviews. They will collect
information on everything from the
political challenges facing media outlets
to examples of successful innovation
with the potential for wider adoption.
Both projects are funded by KfW, the
German development bank. The media
viability study is being conducted in
partnership with DW Akademie, the
international media development
division of Deutsche Welle, Germany’s
public international news agency.
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Uncovering the
history of East Africa’s
Swahili Coast
Archaeological studies shed
new light on the cultural
heritage of the region

An expert in Islamic archaeology,
Professor Stephane Pradines is
delivering new insights into the
history of the Swahili, the Indian
Ocean and the Muslim world.
Prior to joining AKU’s Institute for the
Study of Muslim Civilisations in London
in 2012, Pradines spent a decade at
the French Institute in Cairo leading
major excavations of the walls that
surrounded the city during the Fatimid
era. But his interest in the hundreds
of ruins that dot coastal East Africa,
and that date from the 11th century
onwards, is longstanding. Those
ruins are the remains of Swahili cities
that were important nodes in a vast
trading network that spanned the
Indian Ocean and connected Africa
to the heart of the Islamic world,
as well as to India and China.

Swahili cities were
important nodes in a vast
trading network connecting
Africa to the Islamic world,
India and China.

Long before the arrival of European
explorers, cities such as Mombasa,
Malindi and Kilwa exported gold,
ivory, rock crystal and timber to
the wider world. In return, they
received ceramics, glass and – most
consequentially – Islam. Out of these

exchanges was born the Swahili
civilisation, a hybrid of African, Arab
and Indo-Persian influences.
The archaeologists of the Swahili
coast and adjacent islands has largely
been shaped by scholars who were
Africanists by training. Pradines’
background gives him a different
perspective, helping him to see what
others have overlooked. For example,
in their excavations of Dembeni, a
wealthy city on the island of Mayotte
that thrived from the 9th to the 12th
centuries, Pradines and his team found
numerous fragments of rock crystal.
This translucent form of quartz was
highly valued in Baghdad, Cairo and
elsewhere, where craftsmen carved it
into vases and decorative objects.
While other archaeologists had noted
such fragments in Dembeni, they
speculated they were connected
to the production of iron ore. But
with his knowledge of Fatimid and
Abbasid material culture, Pradines
quickly recognised the rock crystal
as such. He argues it was brought

from Madagascar to Dembeni, where
it was traded for ceramics and other
items before being shipped onward to
the Middle East. Indeed, he suggests
the rock crystal trade could be the
source of much of Dembeni’s wealth.
Dembeni is far from the only African
site where Pradines has conducted
excavations, having worked on
a number of well-known ruins in
Kenya and Tanzania, including Kilwa
Kisiwani, site of the largest medievalera mosque in Sub-Saharan Africa.
He has spent many days living in
a tent on a beach with no running
water, fending off mosquitoes and
hacking away at vegetation to
expose centuries-old stone ruins.
Pradines’ latest project is on the Mafia
archipelago off Tanzania. There, he is
working with the World Monuments
Fund to preserve the ruins of Kua, a
medieval Swahili town, and to enable
them to be safely developed as a
tourist site that benefits the island’s
residents. Eventually, he hopes to see
Kua included on the World Heritage List.
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University of Washington
Seattle, USA

Rockefeller University
New York City, USA

Aga Khan University
Karachi, Pakistan

IRESSEF
Dakar, Senegal

AKU will be working to identify,
understand and prevent potential
pandemic viruses as part of a globespanning partnership supported by
a five-year, US$ 8.75 million grant
from the U.S. National Institutes of
Health’s Centers for Research in
Emerging Infectious Diseases.

FIOCRUZ
Rio De Janeiro, Brazil

AKU joins international
network to identify and
analyse new viruses
Viruses know no boundaries. AKU
is part of a global effort to identify
emerging outbreaks

KRISP
Durban,
South Africa

Led by the University of Washington
(USA), the UWARN partnership
includes Rockefeller University (USA),
FIOCRUZ (Brazil), IRESSEF (Senegal),
KRISP (South Africa) and Chang Gung
University (Taiwan), as well as AKU.
The centres will work to establish
surveillance networks that can
identify disease outbreaks at an early
stage; develop tools for diagnosing
emerging and re-emerging infectious
diseases; and study the genetic makeup of viruses, as well as the body’s
immune response to viral diseases.
“Partners in the network will be
constantly on the lookout for emerging
viruses,” said AKU Associate Professor
Najeeha Talat Iqbal, the project’s

Chang Gung
University
Taipei, Taiwan
principal investigator in Pakistan.
“When we find them, our goal will be
to increase our knowledge of how they
affect the body so that we can improve
our recognition of signs of severe
disease and develop therapies that
can improve treatment outcomes.”
Pakistan is a hotspot for vector-borne
illnesses and has seen four outbreaks
of infectious diseases, other than
COVID-19, over the past decade.
AKU will use its countrywide
network of laboratories to collect
samples of emerging viruses for
genetic analysis and enrol hospital
patients in studies to monitor
their response to treatment.
Public health researchers, basic
scientists, infectious disease
specialists and pathologists at AKU
will be involved in the study.
Dr Iqbal’s co-investigators are
Associate Professor Farah Qamar,
Assistant Professor Ali Faisal
and Professor Erum Khan.
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Novel insights
into gut health
and stunting
in children
Partnerships with U.S.
universities enable pioneering
work in artificial intelligence
and diagnostics

AKU researchers are conducting
pioneering research into the causes of
malnutrition and its inter-generational
consequences, in partnership
with faculty at the University of
Virginia and imaging specialists at
Massachusetts General Hospital, an
affiliate of Harvard Medical School.
Environmental enteric dysfunction
(EED) – often referred to as a neglected
disease of poverty – is thought to be
a leading cause of stunting in children
in the developing world. EED hinders
the gut’s ability to absorb essential
nutrients, compromising children’s
growth and leaving them vulnerable to a
range of diseases. It is thought to be the
result of chronic inflammation owing to
continuous oral exposure to fecal matter
18

through contaminated food and water
in communities that lack clean water.
With funding from the Bill & Melinda
Gates Foundation, Professor
Asad Ali is working alongside
University of Virginia Assistant
Professor Sana Syed to harness
the power of artificial intelligence
to uncover patterns in biopsies of
malnourished children’s guts.
Software the researchers developed
uses the same principles as facial
recognition technology to compare
images of healthy intestines to
those affected with EED.
The software learns to recognise
patterns as it analyses more

images and eventually should be
able to pinpoint the cellular-level
differences that trigger the disorder.
Dr Ali and Dr Syed believe their work
will generate insights that transform
how doctors diagnose EED. At present,
the only way to conclusively identify the
disease is through a biopsy, an invasive
and expensive procedure that requires
sedating children in order to extract
tissue samples from their intestines.
Their goal is to identify a comprehensive
set of screening biomarkers – chemical
warning signs – that would enable
clinicians to diagnose EED through a
simple blood or urine test, and that
could also be used to assess nutritional
or pharmacological interventions aimed
at reducing the effects of the disease.

Dr Ali is also testing a new device
in partnership with Professor Gary
Tearney of Harvard Medical School.
It promises to give the first-ever
insights into the gut health of pregnant
women. Those insights could be used
to improve the health and nutritional
status of both pregnant women

The goal is to identify
a comprehensive set of
screening biomarkers
that enable clinicians
to diagnose EED
through a simple
blood or urine test.

and their babies, as malnourished
mothers are much more likely to give
birth to malnourished children.
Until now, assessing the gut health of
expecting mothers was not possible
because it was not possible to perform
gut biopsies due to the risks involved
in administering anaesthesia during
pregnancy. Researchers will test a
new trans-nasal scope that does not
require patients to be anaesthetised.
It consists of a slender tube that can
be moved down the nose, through the
throat to the gut. The tube contains a
camera, a device that sends electrical
pulses through the intestine to assess
nutrient absorption capacity, a brush to
collect tissue samples and cryobiopsy
technology that freezes samples

to preserve them for analysis. The
scope will be piloted on 150 pregnant
women in the U.S. and Pakistan.
Part of the trial will be conducted at
AKU’s Matiari Research and Training
Centre, which is located in an area
where malnutrition is common, and
where the University has earned the
trust of residents over many years.
“Our ultimate goal is to take this
technology to the doorsteps of the
malnourished,” Dr Ali said. “This
will enable us to easily assess the
severity of malnutrition in women and
children living in high-risk areas. In
the long term, we hope to use this to
test the success of different nutrition
interventions by capturing before and
after images of an individual’s intestine.”
19

Educating parents on
the power of play in early
childhood development
Providing children with a stimulating
environment in their earliest years can
benefit them throughout their lives

AKU RESEARCH

AKU’s Institute for Human Development
(IHD) is conducting a study designed
to furnish information that can be
used to expand programmes that
encourage parents to play and
communicate with their young children
in ways that promote their intellectual,
emotional and social development.
UNICEF’s Care for Child Development
(CCD) intervention package encourages
“playful parenting” – an approach
that sees parents communicate with
their children even before they are
able to speak, play developmentally
appropriate games with them and
encourage their questions and curiosity.

AKU plans to build an
online hub for early
childhood development
that enhances access
to technical resources
and experts.

Under the Scaling Up Playful Parenting
(SUPP) project, faculty will produce case
studies of Care for Child Development
programmes in Kenya, Tanzania,
Uganda and Syria. The studies will be
based on focus group discussions and
individual interviews. Researchers will

also examine how CCD programmes
can be adapted to meet the needs of
parents and children in areas affected
by conflict or a high burden of HIV/AIDS.
Preliminary investigations have revealed
the existence of a wide range of
standalone CCD programmes that
are not integrated into government
schemes and tend to be short-lived.
“Early childhood development
interventions such as Care for Child
Development represent one of the best
ways to build strong, prosperous and
stable societies,” said IHD Director
Amina Abubakar. “The findings of
our study will help policymakers
and practitioners to determine how
best to go about educating parents
on caregiving approaches that help
children to fulfill their potential.”
As part of the project, IHD is identifying
individual programmes’ gaps and

resource requirements, with a view
to conducting capacity-building
sessions for programme staff.
IHD’s capacity-building
experience in East Africa includes
trainings on the Science of Early
Childhood Development.
IHD will also help universities in
Kenya and Zambia to integrate playful
parenting and key child development
topics into degree and professional
development programmes.
In addition, the Institute plans to build
an online hub for early childhood
development that enhances access to
technical resources and experts, thereby
empowering practitioners to scale up
initiatives wherever they may be.
SUPP is funded by UNICEF,
the Lego Foundation and the
Aga Khan Foundation.
23
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Enhancing
access to
sustainable
water supplies

Access to clean water and sanitation in
the Global South is often hampered by
the failure of governments to develop
the necessary infrastructure. Even when
governments do invest in infrastructure,
it often deteriorates because users
cannot or will not pay water tariffs.
Community-based water management
(CBWM) attempts to solve the
problem by mobilising community
members to pay for and operate water
infrastructure. In the mountainous
Gilgit-Baltistan region of northern
Pakistan, the Aga Khan Agency for
Habitat (AKAH) has introduced CBWM
in more than 400 rural communities
totaling 100,000 households,
through its Water and Sanitation
Extension Programme (WASEP).

Exposed water systems
are prone to damage,
illegal connections,
contamination and
freezing. Burying pipes
helps prevent such
problems.

So far, CBWM appears to have
worked well in rural areas with
small and presumably tightly knit
communities. AKAH is now scaling
up WASEP to more urban areas in
the region that have much larger
and more transient populations
and different social dynamics.
To determine if scaling-up is feasible,
AKU’s Institute for the Study of
Muslim Civilisations (ISMC) in London
has launched a study of WASEP

across Gilgit-Baltistan, including
two large recent urban water
schemes in Jutial and Danyore.
The study brings together researchers
in economics, anthropology,
geography, the environmental sciences
and engineering from ISMC and
Karakoram International University
(KIU) in Gilgit, as well as engineers
and development practitioners from
AKAH. ISMC Associate Professor
Jeff Tan, an economist who has
published on water and infrastructure
privatisation, is the project’s principal
investigator. Co-investigators are
ISMC Professor Stephen Lyon and
Professor Attaullah Shah of KIU.
Evidence for the study will be
drawn from interviews with 1,200
households in more than 60 WASEP
and non-WASEP control sites across
Gilgit-Baltistan, along with focus
group discussions, water quality
testing and engineering audits.
The study focuses on the factors that
influence the willingness of community
members to make monetary and
in-kind contributions to construct
infrastructure, and to make monthly
tariff payments. It will examine whether
successful social mobilisation is

related to the size of a community,
wider institutional support, religious
affiliation, education levels and social
structures. It will look into sources
of conflict such as the passage of
pipes over privately owned land and
whether issues related to social status
or sectarianism undermine social
mobilisation within a community.
The study will also investigate how local
terrain affects project management,
and the extent to which women
benefit from and contribute to social
mobilisation and improved health
and hygiene outcomes. “Sustainable
water systems are at the heart of
thriving communities,” Tan said. “This
study will generate valuable lessons
on the social, economic, cultural
and technical factors that govern the
management of scarce water resources
and enable local communities
to improve their livelihoods.”
The research team hopes that the
lessons learned will be of interest not
only to AKAH but to the Government of
Gilgit-Baltistan and actors elsewhere
in the developing world where access
to water is a problem. The twoyear project is funded by the British
Academy’s Urban Infrastructures
of Well-Being programme.
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America and
Islam in the age
of Trump

AKU alerts
government to
HIV/AIDS outbreak
in children

Dean Lawrence Pintak’s
latest book explores America’s
complex relationship with
the Muslim world

AKU researchers revealed how the disease
spread using phylogenetic analysis

AKU has been at the forefront of the
provincial, national and international
response to an outbreak of HIV/AIDS
that infected nearly 1,200 children in
Larkana District, Sindh. The University
was the first to alert officials of an
outbreak, and has been advising
government, providing patient care
and training health workers, as well
as publishing the most in-depth
study of the outbreak to date, in
The Lancet Infectious Diseases.
With funding from the World Health
Organization, Associate Professor Syed
Hani Abidi and colleagues studied the
outbreak using phylogenetic analysis.
They found that the HIV strains involved
(known as CRF02_AG and A1) likely
originated among people who inject
drugs. Nationally, around 40 per cent of
adult intravenous drug users have HIV/
AIDS, and Larkana has a significant
population of people who inject drugs.
Poor infection control practices in
health facilities then allowed the strains
circulating among drug users to be
transmitted to children. While initial
media reports implicated a single local
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HIV-positive doctor in the outbreak,
AKU researchers found multiple
clusters within the outbreak, indicating
a number of healthcare facilities
contributed to the spread of the virus.
That suggests that poor infection
prevention practices are widespread.
Today, 98 per cent of the infected
children are taking antiretroviral drugs
and should be able to lead long and
generally healthy lives. That is partly
thanks to AKU. University staff assisted
with screening the population, opening
a new clinic for HIV-positive children,
treating hundreds of patients in Larkana
and training health professionals in
managing patients with HIV/AIDS. Yet
much remains to be done, according

Poor infection control
practices in health
facilities allowed
strains of the virus to
move from drug users
to children.

to Associate Professor Fatima Mir,
lead author of the Lancet article.
“It’s unconscionable that these
children were infected,” Dr Mir said.
“The government response to the
outbreak has been commendable,
but now we need to see a major effort
to improve infection control in both
the public and private sectors.”
Study co-investigators included
Associate Professor Syed
Faisal Mahmood and Associate
Professor Rehana Siddiqui.

An award-winning, globe-trotting
journalist and an accomplished
academic with a PhD in Islamic
Studies, Lawrence Pintak became Dean
of AKU’s Graduate School of Media
and Communications in Nairobi in
mid-2020. His latest book is America
& Islam: Soundbites, Suicide Bombs
and the Road to Donald Trump. A
finalist for the Religion News
Association’s Awards for Religion
Reporting Excellence, America &
Islam offers a wide-ranging tour
of America, the Muslim world and
relations between the two in the age
of Trump.
In his opening pages, Pintak
analyses the context in which Trump’s
Islamophobia found an audience. He
discusses America’s long history of
Middle East misadventures; the
media’s willingness to hand Trump
a megaphone in its quest for ratings
and profits; the fact that Trump’s
prejudices were echoed by well known
Republicans; and the rise
of ISIS, which helped to revive
fears that had slowly dissipated in
the years after Sept. 11, 2001.

In the latter part of the book, Pintak
seeks to supply the nuance missing
from many discussions of Islam and
extremism. He charts the diversity
of Muslim belief, chronicles “how
the West created radical Islam,” and
clarifies the meaning of key terms
ranging from Islamism to sharia. Turning
from religion to politics, he probes
the rivalry between Saudi Arabia and
Iran, Turkey’s Ottoman dreams and
the growth of Russian and Chinese
influence from Islamabad to Damascus.

Arabia, he sees a “a huge constituency”
for liberalisation. In Pakistan, he
interviews artist-activists who aim to
battle extremism with comic books.
In Indonesia, he finds widespread
support for Islam as “a living religion
receptive to the modern world.”
Indeed, he finds Muslims “from Lagos
to Lahore…taking steps, large and
small, to tame the extremist beast.”
Returning to America, Pintak finds
the country’s Muslims living in “an
era of contradictions. Never had they
been more under attack, but never
had they been so accepted and
outspokenly proud to be American.”
He concludes on an optimistic note,
citing a survey that found Americans
have a more favourable view of Islam
than ever before. Pintak gives newly
elected U.S. Rep. Ilhan Omar the last
word, quoting her defiant response
to a critic who complained that “the
floor of Congress is now going to
look like an Islamic republic.”

Finally, Pintak turns his gaze to
the future, asking how Muslims’
interpretations of their faith might
change in the years ahead. In Saudi

“Well, sir,” Rep. Omar tweeted,
“the floor of Congress is going
to look like America…And you’re
gonna have to just deal [with it].”

It was against this backdrop that Trump
found it possible to assert that “Islam
hates us,” to conjure the spectre of
crowds of Arab-Americans cheering
the collapse of the World Trade Center
and to call for a ban on Muslims
entering America. Pintak quotes a
law professor’s reaction to the Nov. 9
news of Trump’s election: “For Muslim
Americans, 11/9 feels like 9/11 all over
again: the aftermath is frightening.”
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AKU’s
contributions
to the global battle
against COVID-19
The novel coronavirus is the biggest
challenge facing the world today. In Asia
and Africa, AKU is at the forefront of
the effort to better understand the virus
and its impact, prevent its spread and
identify new ways to treat the infected.
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Remdesivir

Clinical trials test
vaccines, therapeutics
and more

The World Health Organization’s
global Solidarity trial explored the
potential of four drugs (remdesivir,
hydroxychloroquine, lopinavir/ritonavir
and interferon) to treat COVID-19
in hospitalised adult patients. AKU
was one of nearly 400 research sites
around the world chosen to investigate
whether remdesivir, a drug used to
treat Ebola, could help prevent deaths
from the virus or reduce the severity
of the disease. The trial found all
four treatments to have little or no
effect on overall mortality, initiation of
ventilation or duration of hospital stay.

Tocilizumab

In both Karachi and Nairobi, AKU
is contributing to the global effort
to identify safe and effective
COVID-19 vaccines, treatments and
diagnostic tests. Six clinical trials
are underway or have concluded,
five of which are international.
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CanSino and Sanofi vaccines
As the world races to develop a
COVID-19 vaccine, AKU is helping
to evaluate CanSino Biologics’ Ad5nCoV vaccine in Pakistan. A phase III
randomised, double-blind, placebocontrolled multi-country trial is
assessing the vaccine’s safety and
immunogenicity (its ability to provoke
an immune response that protects a
vaccinated person against COVID-19).
The vaccine will be administered to
volunteers over the age of 18 who
have no history of being infected by
the virus. Other hospitals in Pakistan
are part of the trial, which seeks to
include 8,000-10,000 patients across
the country. In Kenya, AKU will
participate in a phase III trial of Sanofi’s
adjuvanted, recombinant protein-based
vaccine. The randomised, double-blind,
placebo-controlled, multi-country trial
is expected to get underway by the
end of 2020. Globally, it aims to enroll
a total of more than 34,000 participants
over the age of 18, including individuals
who have been exposed to COVID-19
and individuals over the age of 65.

AKU’s Clinical Research Unit (CRU) in
Nairobi was part of a global, phase III
clinical trial, EMPACTA, which studied
whether a drug typically used to treat
rheumatoid arthritis, tocilizumab,
could safely prevent the onset of
pneumonia in COVID-19 patients.
Pneumonia is one of COVID-19’s
most common serious complications,
with patients often needing a
ventilator to survive. The randomised,
double-blind, placebo-controlled
trial found that patients on the
drug were 44 per cent less likely to
require mechanical ventilation or
lose their lives to the disease.
AKU was the only site in Africa
outside of South Africa that
participated in the trial.

Convalescent plasma therapy
Convalescent plasma therapy uses
antibodies from individuals who
have recovered from COVID-19 to
treat patients who have severe or
critical forms of the disease. While
many countries have permitted
its use, more data on its safety
and efficacy is still required.
AKU is part of a Pakistan-based,
multi-centre clinical trial to evaluate
the therapy. Antibody-rich plasma from
recovered COVID-19 patients at the Aga
Khan University Hospital, Karachi, will
be used to boost the immune system
of individuals undergoing treatment at
the hospital. Researchers will monitor
each patient’s response and assess
the therapy’s effectiveness through a
range of clinical and laboratory tests.

Rapid antigen test

Hydroxychloroquine
AKU is the only centre in South Asia
participating in the COPCOV trial,
which is assessing whether taking
hydroxychloroquine or chloroquine
prophylactically prevents healthcare
workers exposed to COVID-19
patients from contracting the disease.
Sponsored by the University of Oxford
and funded by the Bill & Melinda Gates
Foundation and other organisations,
the randomised, double-blind, placebocontrolled trial has been deemed to be
of urgent public health importance by
the UK’s National Institute for Health
Research’s Clinical Research Network.
Frontline healthcare workers at AKU are
currently being enrolled into the trial.

AKU is the only centre in Asia
participating in a global, multi-centre
clinical trial of a potentially quicker
and more cost-effective COVID-19
diagnostic test, Abbott’s Panbio rapid
antigen test. The Panbio test can
deliver results in as little as 30 minutes,
compared to 12 hours or more for a
PCR test. It assesses the reaction of
a patient specimen to antibodies on a
testing strip, avoiding the need to send
samples to a laboratory for processing.
The faster reporting of results can
help to limit the spread of the virus.
“If this test proves to be as accurate
as existing methods, then we’ll have
played a part in making available a
COVID-19 test that is faster and also
significantly cheaper than existing
options,” Professor Erum Khan said.
“That would be good not just for
Pakistan but for the entire world.”
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Understanding the
immune system’s
response to COVID-19
AKU’s study will track the
immune response of 400
Kenyans

AKU is contributing to a two-year
study in Kenya designed to illuminate
the immune system’s response to
the novel coronavirus and aid in the
development of vaccines and therapies.
“We’re still very far from knowing how
the immune system protects us from
the virus,” Associate Professor Shahin
Sayed said. “It means that we can’t
explain why some patients recover
with ease, and this limits our ability to
predict who needs more aggressive
treatment and who can be spared the
toxicity and cost of intensive care.”

Researchers will
explore how co-morbid
infections affect the
body’s response to the
novel coronavirus.

Funded by the European and
Developing Countries Clinical Trial
Partnership, the study will enrol 400
individuals from Kenya who have been
infected with COVID-19. Researchers
will obtain clinical histories as well as
blood and nasal swab samples when
a person is first infected with SARSCoV-2. Samples will also be collected at
regular intervals over a two-year period.
This will enable researchers to assess
the most important determinants in
the immune system’s response over
time. Data will also be correlated

with the severity of illness to enable
insights into the interplay between
the virus and the immune response
during the course of the illness.
The study promises to deliver insights
into a range of questions, including
how long antibodies protect a person,
how different parts of the immune
system communicate with one another
to tackle the virus, which types of
white blood cells are most effective
in combating the virus, and what
explains so-called cytokine storms and
the respiratory distress they cause.
Researchers will also evaluate the
effectiveness of antibody tests and
other immunological assays, such
as blood serum testing (serology),
for detecting previous infection with
SARS-CoV-2. As PCR testing is not
always available and can deliver false
negatives, mass serological testing
could be used to determine the number
of people previously exposed to SARSCoV-2 in a given population. That would
give a clearer picture of the overall
spread of the virus. Potentially, this
information could shape governments’
COVID-19 management policies.

Serological tests will also be required for
evaluating the effectiveness of vaccines.
In addition, the study will isolate
monoclonal antibodies from COVID-19
survivors. These antibodies could help
inform vaccine design and assist in the
development of potential therapeutics.
While similar research is ongoing in
other parts of the world, it is important
to undertake such studies in Africa,
where individuals may have concomitant
infections such as tuberculosis, HIV/
AIDS or malaria. The study aims
to explore the impact of such comorbid conditions on the immune
system’s response to SARS-CoV-2.
Led by the KEMRI-Wellcome Trust
Research Programme, the study involves
AKU, the Karolinska Institute, Karolinska
University Hospital, Leiden University
Medical Centre and Mabtech, a Swedish
biotechnology company. Kilifi County
Hospital and the Aga Khan Hospital
in Mombasa are also participating.
Associate Professor Reena Shah
and Professor Mansoor Saleh are
co-investigators on the study.
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An online survey of Kenyan healthcare
workers found nearly two-thirds
may suffer from post-traumatic
stress disorder, 25 per cent have
symptoms of moderate to severe
depression and 40 per cent consume
harmful amounts of alcohol.
Conducted while COVID-19 was
circulating in Asia and Europe but had
yet to reach Kenya, the survey is the
work of Lukoye Atwoli, Professor of
Psychiatry and Dean of the Medical
College, East Africa, as well as faculty
and staff from Moi Teaching and Referral
Hospital and Moi University School of
Medicine. The survey also found that 15
per cent of respondents had moderate
to severe anxiety and 20 per cent
suffered clinically significant insomnia
or were just below the threshold for
clinically significant insomnia.
More than 950 healthcare workers
out of 1,259 contacted filled out the
survey, which consisted of standardised
questionnaires such as the World
Health Organization’s Alcohol Use
Disorder Identification Test (AUDIT)
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Study finds stress
among Kenyan
health workers

Expanding Pakistan’s
intensive care capacity
for COVID-19

Researchers launched a hotline
so health professionals can get
counselling

A nationwide study of critical
care facilities informs efforts to
strengthen the healthcare system

and the PHQ-9 depression test.
Almost 40 per cent of respondents
were non-specialist doctors, while
16 per cent were specialist doctors,
20 per cent were nurses, 9 per cent
were clinical officers, and the rest
represented other health professions.
Given that Kenyan health workers
were suffering from a high burden of
mental distress prior to the arrival of
COVID-19 in the country, Dr Atwoli and
his collaborators decided to establish
a hotline to provide mental health
support to healthcare workers during

The survey found
Kenyan health
personnel were
suffering from
depression and other
mental health issues
even before the
pandemic arrived.

the pandemic. With the assistance
of various professional associations,
they established a call centre in the
headquarters of the National Nurses
Association of Kenya staffed by clinical
psychologists and counsellors.
The centre fielded calls from 30
healthcare workers in the first month
of its existence. Data on the hotline’s
usage is being collected, and the
researchers plan to conduct a survey
after one year to gauge its impact. They
also continue to analyse the responses
to their initial survey, aiming to identify
factors associated with mental
distress among healthcare workers.

A survey of nearly 80 intensive
care units (ICUs) across Pakistan
conducted by AKU found that despite
their success in obtaining beds and
ventilators during the pandemic,
many ICUs continue to lack crucial
infrastructure and personnel. That could
spell trouble if the country experiences
a second wave of the COVID-19
pandemic, or an outbreak of another
disease that strains ICU capacity.
“High-tech equipment is only a
part of what makes a successful
ICU,” said AKU Associate Professor
Asad Latif, who led the survey.
“You also need trained staff, the
right spaces to treat patients and
systems to maintain quality.”
The survey reported shortages of
negative pressure isolation rooms,
oxygen supplies, nurses and
qualified critical care physicians.
Many ICUs also lacked policies
and protocols for patient care.
Dr Latif and his team consulted
frameworks for health-systems

strengthening before designing a
comprehensive survey to assess
the quality and scope of facilities,
staff, equipment and systems
at ICUs across Pakistan.
“This survey points out the most critical
gaps in our intensive care delivery,”
Dr Latif said. “While investing more
money in the healthcare system is
important, we also need to invest
in building the capacity of staff and
strengthening processes in order to
raise the quality of care in our ICUs.”
The assessment is part of the
University’s broader Tele-ICU initiative.
Under agreements with the Government
of Sindh and the federal Ministry of

Most intensive care
units were short of
infrastructure, trained
personnel and policies
for patient care.

Health, and with funding from the Bill
& Melinda Gates Foundation and the
Dawood Foundation, AKU is working
towards building the capacity of
healthcare workers across the country
to care for COVID-19 patients.
Over 12,000 people have attended the
University’s online workshops on the
use of personal protective equipment,
and AKU’s courses related to the care
of COVID-19 patients have attracted
more than 10,000 participants.
AKU has also established a hotline to
provide teleconsultations to physicians
treating COVID-19 patients, particularly
focusing on government hospitals. To
date, more than 500 frontline healthcare
workers have called the hotline and
consulted with AKU specialists.
At the signing of the agreement
between AKU and the federal Ministry
of Health, Dr Zafar Mirza, then the
Prime Minister’s special assistant
on health, said the partnership “will
contribute to the national effort to
improve recoveries and save lives.”
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What is COVID-19’s
impact on maternal
and child health?
Biorepositories will help researchers
examine how COVID-19 affects pregnant
women and their babies

To date, studies have generated
conflicting findings on how
COVID-19 affects pregnant women
and their babies. AKU researchers
in Nairobi and Karachi aim to
shed new light on the subject.
In Nairobi, a team led by Professor
Marleen Temmerman have been
engaged in a major study of placental
disorders (pregnancy hypertension,
foetal growth restriction, etc.) in
multiple African countries, using a
biobank of samples collected from
women throughout their pregnancy.
The study, known as PRECISE, has
now been expanded to investigate the
impact of the novel coronavirus on
pregnant women and their babies.
The team will conduct regular COVID
testing on more than 1,000 pregnant
women and 250 non-pregnant women,
assess outcomes among those infected
36

and collect and analyse biological
samples to determine whether and
for how long SARS-CoV-2 is present
in blood, urine, umbilical cord blood,
amniotic fluid and other samples, as well
as determine the presence of antibodies
in cord blood and breast milk.
Their study involves women in Kenya,
Uganda, Mozambique, Malawi and
The Gambia. It will shed light on
whether women infected with the
virus are at a greater risk of pre-term
births or pregnancy complications,
and how pregnancy affects the
progression of the disease in women.
“The novel nature of COVID-19 means
there are many areas where we have
no answers,” said Dr Temmerman,
Director of the Centre of Excellence in
Women and Child Health, East Africa.
“Our project will be one of the largest
studies to date of these issues.”

Dr Temmerman brings to the study
decades of experience in studying
HIV/AIDS in pregnant women.
In Pakistan, AKU Associate Professor
Dr Fyezah Jehan and her team will
be using the AMANHI biobank to
understand the spread, severity and
spectrum of COVID-19 in pregnant
women and their newborns. The
AMANHI biobank is part of a World
Health Organization study of maternal
and child health outcomes that spans
eight countries in South Asia and Africa,
with AKU being responsible for sample
collection and analysis in Pakistan.
The biobank has enrolled more than
2,500 women and 2,300 children
who live in the area of Ibrahim
Hyderi in Karachi. The University
has been providing low-cost primary
care health services in the area for
a number of years and has earned

the trust of the local community.
Since approximately 10 per cent of
the cohort is pregnant at any point in
time, the AMANHI biobank is likely to
be a valuable tool in understanding
how COVID-19 affects maternal
and child health in the area.
Researchers will contact women
enrolled in the study to ascertain
whether they have experienced
symptoms of the disease. Samples

“The novel nature of
COVID-19 means there
are many areas where
we have no answers.
Our project will be one
of the largest studies to
date of these issues.”

will also be collected from a cohort
of pregnant women with COVID-19
until 42 days after birth to ascertain
the course of the disease through
pregnancy. COVID-19 antibody
tests will be conducted on study
participants to understand the burden of
COVID-19 and to ascertain the immune
system’s response to the disease.
Indirect impacts of the pandemic
AKU researchers in Pakistan and
Kenya are also examining the
indirect impact of the pandemic
on mother and child health.
In Pakistan, as part of the AMANHI
project, researchers will be looking
to understand how the pandemic
has impacted nutrition, breastfeeding
and immunisation of newborns.
Data will be compared with findings
from other AMANHI countries to

shed light on the best strategies
to prevent disruptions to essential
services during pandemics.
In Kenya, Dr Temmerman and her
fellow researchers will consult data
from the Ministry of Health and from
health facilities in Kilifi, Mombasa and
Nairobi to assess trends in healthcare
utilisation. They will also conduct
interviews with service providers to
assess the reasons for changes in
health-seeking behaviour. This will
aid researchers in understanding
the pandemic’s impact on antenatal
and postnatal care, facility deliveries,
family planning and adolescent health.
As a member of a Ministry of Health
working group that is looking at the
delivery of essential health services
during the pandemic, Dr Temmerman
will present the study’s findings to
decision-makers to inform efforts to
improve pandemic preparedness.
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Pakistan continues to experience
a relatively low death rate from
COVID-19 and a high proportion
of mild or asymptomatic cases,
contrary to the expectations of many
experts. Professor Zahra Hasan and
her team are working to understand
why by examining the biology of
both the virus and its human hosts.
“The nature of the pandemic here
in Pakistan has given rise to a lot
of speculation,” Hasan said. “Why
hasn’t it been worse? Is it because
Pakistanis have a high level of
immunity? Is it because our population
is so young? We’re working to
deliver rigorous explanations by
analysing the genetic makeup and
diversity of SARS-CoV-2 strains.”
Hasan’s team has conducted whole
genomic sequencing of the virus and
has identified four different families
of strains that were circulating in
Pakistan at the start of the pandemic.
They are analysing these strains
alongside more current strains to
38
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Researching the
role of genetics
in SARS-CoV-2

Casual attitude to
COVID-19 in Pakistan
is cause for concern

Why hasn’t the virus been more
deadly in Pakistan? Genetic
analysis may deliver answers

Researchers found very different
attitudes to the virus in Pakistan
and Hong Kong

understand their variability and possible
mutations in proteins – especially the
spike protein or outer-coat proteins
of the virus – that may cause different
strains to be more infectious or deadly.
Biological differences between
individuals can influence how they
respond to viral infections. Researchers
are studying genetic changes in
blood samples gathered from mildly,
moderately and critically ill COVID-19
patients at the Aga Khan University
Hospital in Karachi to identify
biomarkers that lead to unfavourable
outcomes or protection from the virus.

The research team was able to
jumpstart COVID-19 research as their
SARS-CoV-2 sequencing builds on
previous pathogen genomics work
conducted alongside Professor Rumina
Hasan. Their COVID-19 immunity
work builds on the department’s
ongoing research into tuberculosis
and other infectious diseases.

They are also collaborating with
researchers at Nova University
Lisbon to explore the role of
protective antibody responses in the
progression of COVID-19 in patients.

The research team includes Rumina
Hasan, Najia Ghanchi, Kiran Iqbal, Erum
Khan, Asghar Nasir, Akbar Kanji and
Safina Razzak from the Department of
Pathology and Laboratory Medicine;
Faisal Mahmood, Nosheen Nasir and
Bushra Jamil from the Department of
Medicine; Hani Abidi and Kulsoom
Ghias from the Department of
Biological and Biomedical Sciences;
and Waqasuddin Khan from the
Department of Paediatrics.

“The fact that we have a high incidence
of mild disease is very noteworthy,”
Hasan said. “It opens up the possibility
that we could help deliver answers
to fundamental questions about the
virus that have global implications.”

Research support has been provided
by Health Security Partners in the
United States, Pakistan’s Higher
Education Commission and AKU’s
University Research Council and
Provost’s Academic Priorities Fund.

One in six Pakistani adults believes
that they and their families are safe
from COVID-19 even if they take no
preventive measures, according to
an online survey by AKU and The
Chinese University of Hong Kong.

“The relatively casual attitude of
literate Pakistanis toward COVID-19
is concerning,” said AKU Professor
and Associate Vice Provost for
Research Fauziah Rabbani, the
study’s principal investigator.

the government,” Dr Rabbani said.
“Pakistanis are fortunate to have
proactive government campaigns about
mask use and physical distancing
but have been relatively reluctant
to adopt preventive measures.”

The survey was conducted in May
2020 and gathered responses from
1,406 Pakistanis and 1,715 Hong Kong
residents. It found that Pakistanis
were less concerned about COVID19’s complications and felt they were
more likely to survive the virus than
those surveyed in Hong Kong.

Compared to Hong Kong residents,
Pakistanis were more trusting of
government information sources.
Nearly eight out of ten Pakistanis
rated government information
as being reliable or very reliable
compared with just 16 per cent
of people in Hong Kong.

Forty-one per cent of Pakistanis rated
COVID-19 symptoms as being severe
or very severe, compared to 97 per
cent of respondents in Hong Kong.
Sixty-eight cent of Pakistanis said
they had a high or very high chance of
surviving the disease against 36 per
cent of respondents in Hong Kong.

“In Hong Kong citizens took charge
of the pandemic as they didn’t trust

The survey also found evidence that
Pakistani men and women responded
to the pandemic differently. Despite
a government-imposed lockdown,
only 71 per cent of men said they
avoided going out, compared to 87
per cent of women. Sixty-two per
cent of women reported experiencing
symptoms of anxiety, compared to
50 per cent of men. Men in Pakistan
preferred to acquire information
about the pandemic from their family
and friends, while women viewed
information from doctors as being
more reliable. In both countries, threequarters of respondents said they were
avoiding going to hospitals or clinics.

Pakistanis were also less likely to seek
out information on preventive measures
and how to detect COVID-19 symptoms
than their counterparts in Hong Kong.

41% of Pakistanis
rated COVID-19
symptoms as being
severe or very severe,
versus 97% of Hong
Kong residents.

Drs Adeel Abid, Hania Shahzad,
Hyder Ali Khan, Suneel Piryani and
Ms Areeba Raza Khan contributed to
the study.
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University
updates
AKU continues to strive to
achieve its mission of solving the
developing world’s most pressing
problems by piloting and patenting
new technologies, publishing
groundbreaking studies in landmark
journals, launching new centres
for research and by continuing
to invest in its infrastructure
for knowledge generation.
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AKU innovation
delivers
problem-solving
technologies
UV-light disinfection device

Researchers have developed and
patented several new technologies
3D-printed nasal swabs

The University’s Technology Innovation
Support Centre (TISC) works with
faculty and staff to create new
technologies that can help to solve a
wide range of problems. The Centre has
either led or facilitated the development
of the following technologies.

Multipurpose scope
Despite significant technological
advances, healthcare professionals
continue to use multiple bulky and
expensive devices to examine
different parts of the human body. For
example, dermascopes, otoscopes,
ophthalmoscopes, otolaryngoscopes
and dental scopes are used for
examining skin, ears, eyes, nose,
throat, teeth and more. Traditional
devices also lack the ability to
capture and share images.
To overcome these problems, AKU
has developed a scope with different
end-points that attach to a mobile
phone’s camera. The probes turn the
camera into a multipurpose scope
that can be used to examine and
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capture images of the skin, ears,
eyes, throat, nose and oral cavity.
An accompanying app uses artificial
intelligence technology to analyse the
images. The app also enables image
sharing, which can help boost access
to healthcare in remote areas where
specialists are not easily accessible.
The University has been issued a
U.S. patent for this technology.
A clinical trial of the device is expected
to begin by the end of 2020. Pilot
studies will also be conducted in
remote, rural regions of Central Asia.

Portable emergency ventilator
A portable, low-cost emergency
ventilator developed by TISC is currently
undergoing clinical trials. Unlike
traditional bag-valve masks, which are
manually pumped and can be difficult
to use properly, the device is powered
by a motor. Briefcase-sized, it is small
enough for use in ambulances. It can
also be used on hospital patients
waiting for a traditional ventilator.

Nasal swabs are used to capture the
sample needed to test individuals for
COVID-19. 3D printing these swabs
in Pakistan can help lower the cost of
testing while supporting the country’s
ability to conduct large numbers of
tests (Pakistan is currently reliant on
imported nasal swabs, which are in
high demand around the world). TISC
is manufacturing swabs using the
University’s 3D printing facilities, and
has completed a clinical trial which
found that they are as safe, user-friendly
and effective as existing swabs. AKU
plans to seek regulatory approval that
would allow it to market the swabs
to other institutions in Pakistan.

CoronaCheck self-screening app
CoronaCheck is a mobile phone
app that enables users to easily and
safely evaluate whether they require a
COVID-19 test by answering a series
of questions regarding their health.
CoronaCheck can help ensure that
people who need testing get it, while
also reducing unnecessary hospital
visits and tests. The app is available
to the public in Pakistan, Tajikistan,
Tanzania, Kenya and Mozambique. It
has helped more than 71,000 users.

The Aga Khan University Hospital,
Nairobi, developed a device that uses
ultraviolet light to disinfect spaces
within the hospital, from offices to
operating rooms. The Hospital uses
the device on a regular basis.

Patented tray to reduce
surgical error

Telemedicine mobile phone app
Elaj Asaan, or Easy Treatment, is
a mobile phone teleconsultation
app developed in collaboration
with the Aga Khan Health Service,
Pakistan (AKHS,P). It allows patients,
including in rural areas, to consult
a doctor without having to travel to
a healthcare facility. The app also
makes it possible to securely maintain
and share medical records, allows
patients to pay for services through
the app and provides patients with the
opportunity to provide feedback on
their consultation. Available in Pakistan
through AKHS,P, the application will also
be launched in Kenya and Tanzania.

The misplacement of surgical
instruments and medical supplies
such as scissors and gauze during
surgeries can lead to problems that
endanger patient safety. The University
has been issued a U.S. patent for a
surgical tray that uses image processing
technology to detect when instruments
are removed from and placed back onto
a tray, helping surgeons and support
staff to keep track of vital equipment.
A clinical trial to test the performance
of the device will be launched soon.
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New research
centres will drive
knowledge creation
The centres will advance knowledge
regarding cancer, the brain, global
health, emergency medicine, global
surgery and more

Five new AKU research centres
will deliver new knowledge in fields
crucial to the health and well-being
of the people of Asia and Africa.

Cancer Centre
Cancer cases in Sub-Saharan Africa
are surging, as western diets and
lifestyles become more common and
life expectancy increases. AKU’s new
Cancer Centre in Nairobi aims to be a
leader in the fight against the disease.
It will combine innovative research
with high-quality clinical care, train
badly needed specialists and promote
prevention and early detection.
Today, with Africa accounting for just 2
per cent of cancer clinical trials, doctors
must prescribe cancer drugs that have
never been rigorously tested in African
populations. AKU will help to change
that as one of the only institutions
in Sub-Saharan Africa to meet
U.S. Food and Drug Administration
requirements for conducting clinical
trials. The Centre will include a Centre
for Women’s Cancer, which will
conduct research on cancers that are
especially common among African
women, such as triple-negative breast
cancer. It will also be well positioned
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to test novel therapies developed
by AKU’s Centre for Regenerative
Medicine and Stem Cell Research.

sister agencies of the Aga Khan
Development Network and leading
organisations worldwide.

The Centre is led by Founding Director
Mansoor Saleh, who was previously
Professor of Medicine and Pathology
at the University of Alabama at
Birmingham (UAB) and Director of
the Phase I Programme of UAB’s
Comprehensive Cancer Center.

With extensive reach in South and
Central Asia and Africa, the Institute
comprises a network of leading scholars
delivering research findings from stateof-the-art laboratories and extensive
field sites in low-income urban and rural
communities. Its efforts are focused on
three areas within the broad context of
health and health-related Sustainable
Development Goals: climate change,
urban development and health; gender
inequality and health; and nutrition,
food security and agriculture.

Institute for Global Health
and Development
The Institute for Global Health
and Development champions
interdisciplinary research and crosssectoral action on major global health
challenges, and seeks to contribute
to the achievement of health-related
Sustainable Development Goals.
The Institute advances its mission
through partnerships with its

AKU’s cancer clinical
trials will bring new
treatments and hope to
patients in East Africa.

The Institute seeks to stimulate
and elevate the scholarship around
global health and development to
tackle “wicked” problems affecting
low- and middle-income countries.
Based in Karachi, the Institute is led by
Founding Director Professor Zulfiqar
Bhutta, a globally renowned, awardwinning researcher in the field of
maternal and child health, a member
of the U.S. National Academy of
Medicine and a Fellow of the Royal
Society of the United Kingdom.

Centre of Excellence in
Trauma and Emergencies
The primary goal of the Centre is to
improve health outcomes for individuals
and populations affected by trauma and
emergencies, which account for more
than half of the total burden of disease
in low- and middle-income countries.
Trauma and emergencies include
motor vehicle crashes, humanitarian
crises, disasters due to climate change
and epidemics. Already, the Centre is
leading a collaborative effort to train
10 million Pakistanis over 10 years in
cardiopulmonary resuscitation and
bleeding control, an initiative that
could help to save numerous lives.
Research will be a core component
of the work of the Centre, which aims
to establish a data capture system in
multiple hospitals in Pakistan, launch
a trauma and emergency medicine
research fellowship, and publish
a growing number of articles each
year. Based in Karachi, the Centre
is led by Founding Director Junaid
Razzak, the 2020 recipient of the
Presidential Lifetime Achievement
Award from the U.S.-based Society
for Academic Emergency Medicine’s
Global Emergency Medicine Academy.

Centre for Global Surgery

Brain and Mind Institute

An estimated 11 per cent of all deaths
globally could be averted with timely
access to surgical care. AKU’s new
Centre for Global Surgery will work
to expand access to high-quality
surgery in low-income countries by
training healthcare professionals in
rural areas, developing standards and
guidelines for surgical personnel and
facilities in low-resource settings and
advocating for government policies that
support increased access to surgery.

Mental illness has risen to the top of
the list of threats to the people and
communities served by AKU. Children
and young people are especially
vulnerable, with large proportions of
the population already suffering the
lifelong consequences of inaction.

The Centre will engage in research
that can inform efforts to improve
surgical care in marginalised areas.
Research projects may range from
studies to determine surgical capacity
in a given region to evaluations of
interventions designed to improve
surgical outcomes. Already, the Centre
has undertaken a survey of hospitals
across Pakistan that revealed there are
multiple underappreciated challenges
to the delivery of surgical care. The
Centre is based in Karachi and is led
by Associate Professor Sadaf Khan,
an experienced general and colorectal
surgeon who is also Associate Dean
of Undergraduate Medical Education.

The Brain and Mind Institute will take an
interdisciplinary approach to improving
mental health, with an emphasis on
aiding high-risk populations, including
children, youth and women.
Bridging the fields of medicine and
nursing, public health, women’s health,
neuroscience, biology, psychiatry,
psychology and the social sciences,
the Institute will offer a platform for the
study of a wide range of brain-related
health conditions and the relationship
between mental and physical illness.
Based in Nairobi, the Institute is led
by Founding Director Zul Merali, who
is Professor Emeritus at the University
of Ottawa’s Faculty of Medicine and
Faculty of Social Sciences and was
previously Founder and Scientific
Director of the Canadian Depression
Research and Intervention Network.
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Research
facilities, oversight
and ethics

INSTITUTIONAL BIOSAFETY
COMMITTEE

SYMPOSIUM ON STEM CELL
SCIENCE AND ETHICS

The Institutional Biosafety Committee
(IBC) continues to work to ensure that
the highest level of biosafety standards
is followed. From January 2019 through
September 2020, the Committee
reviewed 237 project proposals and
material transfer agreements. IBC also
initiated a biosafety training programme
for staff based on the American
Society for Microbiology curriculum.

Stem cell research and regenerative
medicine have the potential to alleviate
suffering for millions of people, which
is why AKU has established a Centre
for Regenerative Medicine and Stem
Cell Research at its Karachi campus
with the support of the University of
California, San Francisco. Yet these
fields raise complex ethical challenges.
To advance understanding of such
issues in the context of a pluralistic
world, the University organised a
Symposium on Stem Cell Science,
Regenerative Medicine, Ethics and
Society together with NOVA University
Lisbon in June 2019. The event featured
leading scientists, ethicists, lawyers
and scholars of religion from Europe,
North America, the Middle East and
Asia. Discussions covered experimental
models of neurodegenerative
diseases, bioethics in the context of
Germany’s Muslim minority, the rise of
unproven stem cell therapies, humananimal chimeras and much more.

In response to the COVID-19 pandemic,
IBC and the Research Office developed
standard operating procedures that
allowed laboratory and field activity
to resume while protecting health
and safety. As part of its efforts, IBC
oversaw fit testing of N95 masks and
training in donning and doffing of
personal protective equipment. It also
worked with the University Hospital
pharmacy to manufacture a disinfectant
for N-95 masks, as disinfectant was
in short supply during the countrywide lock down in Pakistan.

ANIMAL RESEARCH FACILITY

JUMA RESEARCH LABORATORY

The Animal Research Facility on AKU’s
Stadium Road campus is fully functional
and meets international standards for
small animal research laboratories. At
present, the facility is equipped to work
on rabbits, guinea pigs, rats and mice;
has individually ventilated cages for
immune-deficient animals, as required
for stem cell transplantation studies;
and has a dedicated procedure room
where anaesthesia and surgery can be
performed. The University is seeking
international accreditation of the facility.

Twenty-six projects are underway in the
Juma Research Laboratory’s Biosafety
Level 2 lab. These involve research in
the fields of immunohistochemistry, cell
and molecular biology, bacteriology,
virology, parasitology, genetics,
cancer and tissue banking, with
support from national and international
grants. The Laboratory is also
considering establishing a Biosafety
Level 3 COVID-19 biorepository.

The facility was closed during the
first COVID-19 peak in Pakistan to
minimise transmission risks as multiple
animal species were reported to be
susceptible to SARS-CoV-2. Standard
procedures were developed for safe
conduct of animal-based research
and activities have since resumed.
The Ethics Committee for Animal Care
and Use and the Research Office
organised a virtual training workshop
on the Principles of Laboratory
Animal Science in September
2020, which was well attended by
participants from across Pakistan as
well as Saudi Arabia and the US.

The Laboratory is now equipped with
a state-of-the-art next generation
sequencer, MiSeq, from Illumina.
It is supported by technology for
whole genome sequencing – a Qubit
Fluorometer, Veriti Thermal Cycler, Palm
Centrifuge and Vortex Genie. During
lockdown, Laboratory staff continued
working to properly maintain equipment
and consumables and safeguard
bio-samples. Once the lockdown
eased, the Laboratory resumed
normal operations in accordance with
standard operating procedures.

High impact
publications
NEW ENGLAND JOURNAL OF
MEDICINE: RANDOMISED TRIAL OF
AMOXICILLIN FOR PNEUMONIA IN
PAKISTAN
A double-blind, randomized, placebocontrolled non-inferiority trial was
conducted involving children at primary
health care centers in low-income
communities in Karachi, Pakistan.
Children who were 2 to 59 months
of age and who met WHO criteria for
non-severe pneumonia with tachypnea
were randomly assigned to a 3-day
course of a suspension of amoxicillin
(the active control) of 50 mg per milliliter
or matched volume of placebo (the test
regimen), according to WHO weight
bands (500 mg every 12 hours for a
weight of 4 to <10 kg, 1000 mg every
12 hours for a weight of 10 to <14
kg, or 1500 mg every 12 hours for a
weight of 14 to <20 kg). The primary
outcome was treatment failure during
the 3-day course of amoxicillin or
placebo. From November 9, 2014,
through November 30, 2017, a total of
4002 children underwent randomization
(1999 in the placebo group and 2003
in the amoxicillin group). The incidence
of treatment failure was 4.9% among
placebo recipients (95 of 1927 children)
and 2.6% among amoxicillin recipients
(51 of 1929 children, between-group
difference 2.3 percentage points; 95%
confidence interval [CI], 0.9 to 3.7). The
presence of fever and wheeze predicted
treatment failure. The number needed
to treat to prevent one treatment failure

THE BMJ: COVID-19 RISK AND
RESPONSES IN SOUTH ASIA

FRONTIERS IN ONCOLOGY: LACK OF
ANDROGEN RECEPTOR SELECTS
FOR BASAL-LIKE PHENOTYPE

was 44 (95% CI, 31 to 80). One patient
(<0.1%) in each group died. Relapse
occurred in 40 children (2.2%) in the
placebo group and in 58 children (3.1%)
in the amoxicillin group. Among children
younger than 5 years of age with
non-severe pneumonia, the frequency
of treatment failure was higher in the
placebo group than in the amoxicillin
group, a difference that did not meet
the non-inferiority margin for placebo.
Fyezah Jehan, Imran Nisar, Salima
Kerai, Benazir Balouch, Nick Brown,
Najeeb Rahman, Arjumand Rizvi, Yasir
Shafiq, and Anita K.M. Zaidi (2020).
Randomised Trial of Amoxicillin for
Pneumonia in Pakistan. New England
Journal of Medicine 2020; 383:24-34.

Androgen receptor (AR) has emerged
as a significant favorable prognostic
indicator in estrogen-receptor
expressing (ER+) breast cancer (BCa).
However, its clinical and biological
relevance in triple negative breast
cancer (TNBC) and association with
cancer stem cell (CSC) markers
remain ambiguous. We examined the
immunohistochemical expression of AR
in a cohort of stage I–III TNBC cases
(n=197) with long-term clinical follow-up
data (mean follow-up = 53.6 months).
Significance of AR expression was
correlated with prognostic biomarkers
including cancer stem cell markers
(CD44, CD24, and ALDH1), basal
markers (CK5, CK14, and nestin),
proliferation marker (ki-67), apoptotic
marker (Bcl-2), and COX-2. Expression
of CK5 and nestin was used for the
categorization of TNBC into basal
(TN, CK5+, and/or nestin+) and nonbasal (TN, CK5−, and/or nestin−)
phenotypes, and Kaplan–Meier curves
were used for estimation of overall
survival and breast cancer-specific
survival (BCSS). Assessment of AR and

basal markers identified biologically
and clinically distinct subgroups of
TNBC. Expression of AR defined a
low-risk TNBC subgroup associated
with improved overall survival, whereas
expression of basal markers (CK5 and
nestin) identified a high-risk subgroup
associated with adverse BCSS.
Integration of immunohistochemical
analysis of AR and basal biomarkers
to the assessment of TNBC tumors is
expected to improve the prognostication
of an otherwise heterogeneous disease.
Nazia Riaz, Romana Idress, Sadia
Habib and El-Nasir Lalani (2020).
Lack of androgen receptor selects
for basal-like phenotype and is a
predictor of poor clinical outcome in
non-metastatic triple negative
breast cancer. Frontiers in
Oncology 2020; 10:1083.

From what initially seemed like a
localised outbreak in Hubei province
of China in December 2019, it rapidly
became clear that SARS-CoV-2 had
pandemic potential. The number of
deaths from COVID-19 in Italy now
exceeds those reported from China, and
the outbreak in Iran may have seeded
cases in Pakistan and Afghanistan.
The number of reported cases in South
Asia remains relatively low, however,
and the response patchy. By 24
March, authorities in the South Asian
Association for Regional Cooperation
(SAARC), which comprises India,
Pakistan, Bangladesh, Nepal, Sri Lanka,
Maldives, Bhutan, and Afghanistan,
had reported just 1536 confirmed
cases and 22 deaths. Although all
countries took individual actions, it
took the collective political leadership
of SAARC almost two months to put
aside political differences and meet
to discuss the dangers to the region
posed by COVID-19. The actions
of individual countries in SAARC
have varied. Although the potential
economic and social consequences
of such measures could be huge,

allowing the counterfactual reality of
continued regular activities and mass
congregations would be extremely
unwise. Testing at scale is limited,
focusing mainly on individuals
arriving from affected countries and
their immediate contacts. The only
effective intervention implemented
is that all countries in the region
have drastically reduced or stopped
air travel and imposed quarantine
protocols on people arriving by road
or air from countries with COVID-19
transmission. However, facilities for
screening and quarantine remain
limited and of questionable quality.
Zulfiqar A. Bhutta, Buddha Basnyat,
Samir Saha, Ramanan Laxminarayan
(2020). Covid-19 Risk and Responses
in South Asia. British Medical
Journal 2020; 368:m1190.

LANCET GLOBAL HEALTH:
PERFORMANCE OF LATE
PREGNANCY BIOMETRY FOR
GESTATIONAL AGE DATING
This prospective, population-based,
cohort study was done in three LMICs
(Bangladesh, Pakistan, and Tanzania)
participating in the WHO Alliance
for Maternal and Newborn Health
Improvement study. Women carrying
a live singleton fetus dated by crownrump length (CRL) measurements
between 8+0-14+6 weeks of gestation,
who were willing to return for two
additional ultrasound scans, and who
planned on delivering in the study area
were enrolled in the study. Participants
underwent ultrasonography at 24+029+6 weeks and at 30+0-36+6 weeks’
gestation. Statistical modelling was
done to develop new gestational
age prediction formulas for third
trimester ultrasonography in LMICs.
With standard dating formulas, late
pregnancy ultrasound at 24+0-29+6
weeks’ gestation was accurate to within
approximately plus or minus 2 weeks
of the gold standard CRL measurement
of gestational age, and late pregnancy
ultrasound was accurate to within
±3 weeks of the CRL measurement
at 30+0-36+6 weeks’ gestation. By
use of a novel parsimonious model
formula that combined TCD with
femur length, gestational age at the
24+0-29+6-week ultrasound scan
was estimated to within ±10.5 days of
the CRL measurement and estimated
to within ±15.1 days of the CRL

LANCET INFECTIOUS DISEASES:
HIV INFECTION PREDOMINANTLY
AFFECTING CHILDREN IN SINDH,
PAKISTAN
measurement at the 30+0-36+6-week
ultrasound scan. Similar results were
observed in infants who were smallfor-gestational-age. Incorporation of
TCD and the use of new formulas in
late pregnancy ultrasound scans could
improve the accuracy of gestational
age estimation in both appropriatefor-gestational-age and small-forgestational-age infants in LMICs.
Validation of this new formula in other
LMIC populations is needed to establish
whether the accuracy of the late
pregnancy ultrasound can be narrowed
to within approximately 2 weeks.
The WHO Alliance for Maternal and
Newborn Health Improvement Late
Pregnancy Dating Study Group. Nasir
et al. Performance of late pregnancy
biometry for gestational age dating
in low-income and middle-income
countries: a prospective, multi-country,
population-based cohort study
from the WHO Alliance for Maternal
and Newborn Health Improvement
(AMANHI) Study Group. Lancet
Global Health 2020; 8(4):e545-e554.

In this cross-sectional study in April
2019, the outbreak response from
the government, academia, and
UN agencies in Larkana, Sindh,
Pakistan was reviewed. For children
who registered for HIV care, clinical
history of previous injections and
blood transfusions, HIV disease stage,
hepatitis B and hepatitis C status,
and CD4 count was abstracted from
clinical records from Sindh AIDS Control
Program HIV Clinic (Shaikh Zayed
Children’s Hospital, Larkana, Pakistan)
and analysed using percentages, chi(2)
tests, and weight-for-age Z scores.
Between April 24, and July 15, 2019,
31 239 individuals underwent HIV
testing, of whom 930 (3%) tested
positive for HIV. Of these, 763 (82%)
were younger than 16 years and 604
(79%) of these were aged 5 years and
below. Estimated HIV prevalence was
3% overall; 7% (283 of 3803) in children
aged 0-2 years, 6% (321 of 5412) in
children aged 3-5 years, and 1% (148
of 11 251) in adults aged 16-49 years.
Of the 591 children who registered for
HIV care, 478 (81%) were 5 years or
younger, 379 (64%) were boys, and 315
(53%) of 590 had a weight-for-age Z
score of -3.2. Prevalence of hepatitis
B surface antigen was 8% (48 of 574)
and hepatitis C antibody positivity was
3% (15 of 574). Of children whose
mothers tested for HIV, only 39 (11%)

BMJ GLOBAL HEALTH: GLOBAL
STRATEGIES AND LOCAL
IMPLEMENTATION OF HEALTH AND
HEALTH-RELATED SDGS
of 371 had HIV-positive mothers.
Most children (404 [89%] of 453)
reported multiple previous injections
and 40 (9%) of 453 reported blood
transfusions. The outbreak was heavily
skewed towards children younger
than 5 years, with a predominance of
boys. Epidemiological and molecular
studies are needed to understand
the full extent of the outbreak and its
drivers to guide HIV control strategies.
Mir, F., Mahmood, F., Siddiqui,
A. R., Baqi, S., Abidi, S. H., et al.
(2020). HIV infection predominantly
affecting children in Sindh, Pakistan,
2019: a cross-sectional study of
an outbreak. Lancet Infectious
Diseases 2020; 20(3), 362-370.

Evidence on early achievements,
challenges and opportunities would
help low-income and middleincome countries (LMICs) accelerate
implementation of health and healthrelated sustainable development goals
(HHSDGs). Consultative meetings
were conducted during 2018–2019
that involved 15 countries across five
regions to determine the status of
implementation of HHSDGs. Almost
120 representatives from health and
non-health sectors participated. The
assessment relied on a multidomain
analytical framework drawing
on existing public health policy
frameworks. During the first 5 years
of the sustainable development goals
(SDGs) era, participating LMICs from
South and Central Asia, East Africa
and Latin America demonstrated
growing political commitment to
HHSDGs, with augmentation of
multisectoral institutional arrangements,
strengthening of monitoring systems
and engagement of development
partners. On the other hand, there
has been limited involvement of civic
society representatives and academia,
relatively few capacity development
initiatives were in place, a wellcrafted communication strategy was
missing, and there is limited evidence
of additional domestic financing for
implementing HHSDGs. While the

momentum towards universal health
coverage is notable, explicit linkages
with non-health SDGs and integrated
multisectoral implementation strategies
are lacking. The study offers messages
to LMICs that would allow for a full
decade of accelerated implementation
of HHSDGs, and points to the need for
more implementation research in each
domain and for testing interventions
that are likely to work before scale-up.
Sameen Siddiqi, Wafa Aftab, Fahad
Javaid Siddiqui, Luis Huicho, Roman
Mogilevskii, Peter Friberg, Johanna
Lindgren-Garcia, Sara Causevic, Anil
Khamis, Mashal Murad Shah, Zulfiqar
Ahmed Bhutta (2020). Global strategies
and local implementation of health
and health-related SDGs: lessons from
consultation in countries across five
regions. BMJ Global Health; 5:e002859.
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